| Acquirer | Target | Price |
|---|---|---|
| Fresenius Helios | Quironsalud | $6.48 billion |
| Danaher Corporation | Cepheid | $3.87 billion |
| Cardinal Health | Rights to Lymphoseek® in North America | $80 million |
| Allergan plc | RetroSense Therapeutics, LLC | $60 million |
| Aralez Pharmaceuticals Inc. | Rights to Zontivity® in U.S. and Canada | $25 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
